Claude Jolivalt

Prof. Claude Jolivalt


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
EPEstelle Palierse
Estelle Palierse
CHChristophe Hélary
Christophe Hélary
JKJean-Marc Krafft
Jean-Marc Krafft
IGIsabelle Génois
Isabelle Génois
SMSylvie Masse
Sylvie Masse
CJClaude Jolivalt
Claude Jolivalt

26 March 2014 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
AHArnaud Hequet
Arnaud Hequet
OBOlga N. Burchak
Olga N. Burchak
MJMatthieu Jeanty
Matthieu Jeanty
XGXavier Guinchard
Xavier Guinchard
EPEmmanuelle Le Pihive
Emmanuelle Le Pihive
CJClaude Jolivalt
Claude Jolivalt

Verified
Journal Article
Open access
PDF file
EPEstelle Palierse
Estelle Palierse
CPCédric Przybylski
Cédric Przybylski
DBDalil Brouri
Dalil Brouri
CJClaude Jolivalt
Claude Jolivalt
Thibaud CoradinThibaud Coradin
Thibaud Coradin
Chlorogenic (CA) and rosmarinic (RA) acids are two natural bioactive hydroxycinnamic acids whose antioxidant properties can be modulated by the chelation of metal ions. In this work, the interactions of these two carboxylic phenols with calcium ions and the impact of such interactions on their antioxidant activity were investigated. UV-Vis absorbance, mass spectroscopy and 1H and 13C liquid NMR were used to identify complexes formed by CA and RA with calcium. Antioxidant activities were measured by the Bois method. Density functional theory (DFT) calculations were performed to evaluate the most stable configurations and correlated with NMR data. Taken together, these data suggest that calcium ions mainly interact with the carboxylate groups of both molecules but that this interaction modifies the reactivity of the catechol groups, especially for RA. These results highlight the complex interplay between metal chelation and antioxidant properties of natural carboxylic phenols.

6 January 2016 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
FLFrançois Liger
François Liger
PBPascale Bouhours
Pascale Bouhours
CGCarine Ganem‐Elbaz
Carine Ganem‐Elbaz
CJClaude Jolivalt
Claude Jolivalt
SPStéphane Pellet‐Rostaing
Stéphane Pellet‐Rostaing
MLMarc Lemaire
Marc Lemaire

31 July 2023 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
YZYifan Zan
Yifan Zan
FRFerdaous Ben Romdhane
Ferdaous Ben Romdhane
AMAntoine Miche
Antoine Miche
CMChristophe Méthivier
Christophe Méthivier
JKJean-Marc Krafft
Jean-Marc Krafft
JRJulien Reboul
Julien Reboul

1 May 2019 in Molecules
Verified
Journal Article
Open access
PDF file
HBHéloise Boullet
Héloise Boullet
FBFayçal Bentot
Fayçal Bentot
AHArnaud Hequet
Arnaud Hequet
CGCarine Ganem-Elbaz
Carine Ganem-Elbaz
CBChérine Bechara
Chérine Bechara
PKPhilippe KAROYAN
Philippe KAROYAN
Antimicrobial peptides (AMPs) are considered as potential therapeutic sources of future antibiotics because of their broad-spectrum activities and alternative mechanisms of action compared to conventional antibiotics. Although AMPs present considerable advantages over conventional antibiotics, their clinical and commercial development still have some limitations, because of their potential toxicity, susceptibility to proteases, and high cost of production. To overcome these drawbacks, the use of peptides mimics is anticipated to avoid the proteolysis, while the identification of minimalist peptide sequences retaining antimicrobial activities could bring a solution for the cost issue. We describe here new polycationic -amino acids combining these two properties, that we used to design small dipeptides that appeared to be active against Gram-positive and Gram-negative bacteria, selective against prokaryotic versus mammalian cells, and highly stable in human plasma. Moreover, the in vivo data activity obtained in septic mice reveals that the bacterial killing effect allows the control of the infection and increases the survival rate of cecal ligature and puncture (CLP)-treated mice.